![](/img/cover-not-exists.png)
P-118 * Tepotinib (MSC2156119J) monotherapy in patients with MET-positive advanced hepatocellular carcinoma with Child-Pugh Class A liver function who have failed sorafenib treatment: phase Ib/II trial
Faivre, S., Raymond, E., Stammberger, U., Sarholz, B., Bladt, F.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.118
Date:
June, 2015
File:
PDF, 33 KB
english, 2015